Literature DB >> 21484291

A case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatment.

Hideko Nakahara1, Yosuke Kamide, Yoshimasa Hamano, Takashi Hosokawa, Masayuki Nishide, Yu Lin, Keisuke Kawamoto, Mie Fusama, Shinji Higa, Takashi Kuroiwa, Tsuyoshi Igarashi, Taro Kuritani, Keiji Maeda.   

Abstract

A female patient with rheumatoid arthritis (RA) suffered from Mycobacterium avium (M. avium) infection during tocilizumab treatment. Tocilizumab was discontinued and she was treated with a recommended chemotherapy, resulting in improvement of M. avium. Tocilizumab retreatment did not aggravate M. avium infection, and radiographic abnormalities improved over 1 year after cessation of the recommended therapy. Tocilizumab may be one candidate for intractable RA patients with M. avium if any biologic is required.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21484291     DOI： 10.1007/s10165-011-0448-1

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN： 1439-7595            Impact factor:   3.023


  6 in total

Review 1.  The Immunobiology of the Interleukin-12 Family: Room for Discovery.

Authors:  Elia D Tait Wojno; Christopher A Hunter; Jason S Stumhofer
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

2.  Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan.

Authors:  Shunsuke Mori; Hitoshi Tokuda; Fumikazu Sakai; Takeshi Johkoh; Akio Mimori; Norihiro Nishimoto; Sadatomo Tasaka; Kazuhiro Hatta; Hidekazu Matsushima; Shunji Kaise; Atsushi Kaneko; Shigeki Makino; Seiji Minota; Takashi Yamada; Shinobu Akagawa; Atsuyuki Kurashima
Journal:  Mod Rheumatol       Date:  2011-12-30       Impact factor: 3.023

3.  Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: A retrospective cohort study.

Authors:  Shunsuke Mori; Yukinori Koga; Kazuyoshi Nakamura; Sayuri Hirooka; Takako Matsuoka; Hideshi Uramoto; Osamu Sakamoto; Yukitaka Ueki
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

4.  Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report.

Authors:  Takahiro Takazono; Shigeki Nakamura; Yoshifumi Imamura; Taiga Miyazaki; Koichi Izumikawa; Hiroshi Kakeya; Katsunori Yanagihara; Shigeru Kohno
Journal:  BMC Infect Dis       Date:  2014-02-28       Impact factor: 3.090

5.  Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report.

Authors:  Ho Namkoong; Sadatomo Tasaka; Mitsuhiro Akiyama; Kazuma Yagi; Makoto Ishii; Katsuya Suzuki; Mitsutomo Kohno; Naoki Hasegawa; Tsutomu Takeuchi; Tomoko Betsuyaku
Journal:  BMC Pulm Med       Date:  2015-10-23       Impact factor: 3.317

6.  Development of Rheumatoid Arthritis in Cavitary Mycobacterium avium Pulmonary Disease: A Case Report of Successful Treatment with CTLA4-Ig (Abatacept).

Authors:  Hiromu Tanaka; Takanori Asakura; Jun Kikuchi; Makoto Ishii; Ho Namkoong; Yuko Kaneko; Koichi Fukunaga; Naoki Hasegawa
Journal:  Infect Drug Resist       Date:  2022-01-11       Impact factor: 4.003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.